Related references
Note: Only part of the references are listed.Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids
Thuy Nguyen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance
J. G. Ramaekers et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
A Brief Background on Cannabis: From Plant to Medical Indications
Linda E. Klumpers et al.
JOURNAL OF AOAC INTERNATIONAL (2019)
Endocannabinoid and Prostanoid Crosstalk in Pain
Baptiste Buisseret et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Crystal Structure of the Human Cannabinoid Receptor CB2
Xiaoting Li et al.
CELL (2019)
Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex
Kaavya Krishna Kumar et al.
CELL (2019)
Blocking Alcoholic Steatosis in Mice with a Peripherally Restricted Purine Antagonist of the Type 1 Cannabinoid Receptor
George S. Amato et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
GPU-Accelerated Molecular Dynamics and Free Energy Methods in Amber18: Performance Enhancements and New Features
Tai-Sung Lee et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2018)
Focus on Cannabinoids and Synthetic Cannabinoids
R. Le Boisselier et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2017)
Crystal structures of agonist-bound human cannabinoid receptor CB1
Tian Hua et al.
NATURE (2017)
Cannabinoid signaling in health and disease
Yan Lu et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2017)
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity
Partha Mukhopadhyay et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Crystal Structure of the Human Cannabinoid Receptor CB1
Tian Hua et al.
CELL (2016)
High-resolution crystal structure of the human CB1 cannabinoid receptor
Zhenhua Shao et al.
NATURE (2016)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems A Clinical Review
Kevin P. Hill
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Improving Docking Results via Reranking of Ensembles of Ligand Poses in Multiple X-ray Protein Conformations with MM-GBSA
P. A. Greenidge et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Toward Fully Automated High Performance Computing Drug Discovery: A Massively Parallel Virtual Screening Pipeline for Docking and Molecular Mechanics/Generalized Born Surface Area Rescoring to Improve Enrichment
Xiaohua Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Differentiation between low- and high-efficacy CB1 receptor agonists using a drug discrimination protocol for rats
Torbjoern U. C. Jaerbe et al.
PSYCHOPHARMACOLOGY (2014)
MM/GBSA Binding Energy Prediction on the PDBbind Data Set: Successes, Failures, and Directions for Further Improvement
Paulette A. Greenidge et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Knowledge-Based, Central Nervous System (CNS) Lead Selection and Lead Optimization for CNS Drug Discovery
Arup K. Ghose et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Design and Synthesis of Cannabinoid Receptor 1 Antagonists for Peripheral Selectivity
Alan Fulp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Diphenyl Purine Derivatives as Peripherally Selective Cannabinoid Receptor 1 Antagonists
Alan Pulp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Assessing the Performance of the Molecular Mechanics/Poisson Boltzmann Surface Area and Molecular Mechanics/Generalized Born Surface Area Methods. II. The Accuracy of Ranking Poses Generated From Docking
Tingjun Hou et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2011)
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Roger G. Pertwee
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
3-[2-cyano-3-(trifluoromethyl)phenoxy]phenyl-4,4,4-trifluoro-1-butanesulfonate (BAY 59-3074):: A novel cannabinoid CB1/CB2 receptor partial agonist with antihyperalgesic and antiallodynic effects
J De Vry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271
F Mauler et al.
BRAIN RESEARCH (2003)
Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties
F Mauler et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Molecular properties that influence the oral bioavailability of drug candidates
DF Veber et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Share Paper
